Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Numeco is a French medical device company, part of the Laboratoire ProtecSom group, specializing in the design and manufacture of respiratory care products. The company focuses on aerosol therapy and oxygen therapy, offering a range of valved holding chambers (spacers), nebulizers, and masks designed to optimize drug delivery for patients with asthma, COPD, and other respiratory conditions. Their flagship products, such as the Tips-Haler, are engineered to improve the deposition of inhaled medications in the lungs while minimizing oropharyngeal side effects. Numeco operates primarily in the European market, providing solutions for both clinical and home-care settings. The company is recognized for its commitment to technical innovation and its collaboration with healthcare professionals to improve patient adherence and inhalation technique.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Numeco.